Synthesis and Crystal Structure of Ag_2(admtrz)_2(CF_3CO_2)_2(admtrz=4-amino-3,5-dimethyl-1,2,4-triazole)

The title compound (Ag2F6O4N8C12H16, Mr = 666.07) was synthesized and its crystal structure was determined by single-crystal X-ray diffraction method. It crystallizes in orthorhombic, space group Fddd with cell parameters: a = 12.2718(1), b = 23.3229(1), c = 29.1918(1) ? V = 8355.10(8) 3, Z = 16, Dc = 2.118 g/cm3, F(000) = 5184 and m = 1.966 mm-1. The structure was solved by direct methods and refined by full-matrix least-squares methods. The final R = 0.0624 and Rw = 0.1699 for 1584 observed reflections with I ≥ 2.0s(I). The molecular structure consists of two trigonal silver atoms bridged by double triazole ligands. The distance between the two silver atoms Ag(1)…Ag(1A) is 3.475(2) ?

Synthesis and Molecular Structure of 1,5,1',5'-Tetraphenyl-1H,1H'-3,3'-dialkylthio-bi-1,2,4-triazole

The title compound 1,5,1 ＇,5 ＇-tetraphenyl- 1H, 1H＇-3,3 ＇-dialkylthio-bi-1,2,4-triazole （2, C28H20N6S2, Mr = 504.62） was prepared by the reaction of 1-benzoyl-3-phenylaminothiourea 1 and Mn（OAc）3·2H2O in acetic acid under microwave irradiation. The crystal is of monoclinic, space group P21/c with a = 11.3931（10）, b = 16.5787（14）（c = 26.470（2） A, β = 98.274（2）°, Z = 8, V = 4947.8（8） A3, 1）, = 1.355 g/cm^3,μMoKa） = 0.245 mm^-1, F（000） = 2096, the final R = 0.0583 and wR = 0.1502 for 8705 observed reflections （I〉 20（I））. X-ray analysis reveals that the title compound is 1,5,1 ＇,5 ＇-tetraphenyl- 1 H, 1 H＇-3,3 ＇-dialkylthio-bi- 1,2,4-triazole, and its formation mechanism was proposed.

Synthesis and Molecular Structure of 1,5-Diphenyl-3-phenacylthio-1H-1,2,4-triazole

The title compound 1,5-diphenyl-3-phenacylthio-1H-1,2,4-triazole 2 （C22H17- N3OS, Mr = 371.45） was prepared by the reaction of 1-benzoyl-3-phenyl-aminothiourea 1 with 2-bromoacetophenone. The crystal is of triclinic, space group P^1-, a = 8.906（3）, b = 9.853（3）, c = 11.226（4）A, α= 100.562（5）, β= 101.285（5）, γ. = 105.096（6）^c, Z = 2, V = 903.7（5） ]A^3, Dc= 1.365 g/cm^3,μ（MoKa） = 0.196 mm^-1, F（000） = 388, the final R = 0.0506 and wR = 0.0985 for 2532 observed reflections （I〉 2σ（I））. Its formation mechanism was proposed.

Synthesis, Crystal Structure and Antitumor Activity of 4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)-N-(2-hydroxy-3,5-diiodinebenzyl)-thiazol-2-amine

The title compound, 4-（tert-butyl）-5-（1 H- 1,2,4-triazol- 1 -yl）-N-（2-hydroxy-3,5-diio- dinebenzyl）thiazol-2-amine, was synthesized via the reduction of 4-（tert-butyl）-5-（1H-l,2,4- triazol-l-yl）-N-benzylidene-thiazol-2-amine with NaBH4, and its crystal structure was determined by single-crystal X-ray diffraction. The compound crystallizes in monoclinic system, space group P21/c with a = 7.91944（19）, b = 10.5250（3）, c = 24.4985（6） A, Z = 4, V = 2041.66（9） A3, Mr = 599.22, Dc = 1,949 Mg/m3, S = 1.120, p = 3.203 mm-1, F（000） = 1152, the final R = 0.0283 and wR = 0.0592 for 3490 observed reflections （I 〉 2σ（I））. X-ray analysis displays that the crystal water takes part in three intermolecular hydrogen bonds of O（2）-H（2A）…O（1）, O（2）-H（2B）…N（I） and N（5）-H（5）…O（2）, and an octatomic ring R^（8） is formed via intramolecular hydrogen bond of O（I）-H（IA）…N（4）. Furthermore, the I…I contacts are involved in stabilizing the overall three-dimensional network structure. The preliminary biological test shows the title compound has good antitumor activity with the IC50 value of 26 μM against the Hela cell line.

Synthesis, Crystal Structure and Antitumor Activity of (E)-1-(7-Methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-5- yl)-3-(2-methoxyphenyl)-2-(1H-1,2,4-triazol-1-yl)propenol

The title compound, （E）-1-（7-methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl）- 3-（2-methoxyphenyl）-2-（1H-1,2,4-triazol-1-yl）propenol （3a）, was synthesized by the Aldol con- densation reaction of 1-（7-methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl）-2-（1,2,4-triazol- 1-yl）ethanone with 2-methoxybenzaldehyde and then reduced with NaBH4, and its crystal structure was determined by single-crystal X-ray diffraction： monoclinic system, space group P21 with a = 6.2002（3）, b = 12.8452（7）, c = 13.2257（7） ？, Z = 2, V = 1031.23（9） ？3, Mr = 407.46, Dc = 1.312 Mg/m3, S = 1.054, μ = 0.091 mm-1, F（000） = 432, the final R = 0.0353 and wR = 0.0769 for 3161 observed reflections （I 〉 2σ（I））. X-ray analysis displays that the title compound adopts an E configuration for the C（7）=C（8） double bond and S configuration for the chirality center with the specific rotation of –63.75°. Furthermore, the stability of the crystal was maintained through the intermolecular hydrogen bond O（1）–H？？？N（3）. The antitumor assay exhibits that the title compound 3a （E configuration） has a good antitumor activity against the Hela cell line with the IC50 value of 36.9 μM, which is better than that of 3b （Z configuration）.

Synthesis, Crystal Structure and Fungicidal Activity of (Z)-3,3-Dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-one O-2-Chlorobenzyl Oxime Nitrate

The title compound has been synthesized by the reaction of 3,3-dimethyl-1-（1H-1,2,4-triazol-1-yl）butan-2-one oxime with 2-chlorobenzyl chloride, and then treated with 65～68% HNO3. Its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group P21/c with a = 14.5481（8）, b = 9.3351（5）, c = 13.1911（7） , β = 98.9450（10）°, Z = 4, V = 1769.67（17） 3, Mr = 369.81, Dc = 1.388 g/cm3, S = 1.06, μ = 0.247 mm-1, F（000） = 776, the final R = 0.0352 and wR = 0.0960 for 3069 observed reflections （I 2σ（I））. X-ray crystal structure presents the intramolecular N–H…O hydrogen bond. The packing is nearly parallel without π-π stacking interactions between two adjacent phenyl rings and stabilized by Van der Waals force. The preliminary bioassay shows that the title compound possesses fungicidal activity against Gibberella zeae at the dosage of 25 mg/L.

Synthesis,Crystal Structure and Plant Growth Regulatory Activity of 1-(3-Amino-[1,2,4]triazol-1-yl)-3,3-dimethyl-butan-2-one

The title compound 1-（3-amino-[1,2,4]triazol-1-yl）-3,3-dimethyl-butan-2-one（3） was synthesized by Hofmann-alkylation reaction of 1-chloro-3,3-dimethyl-butan-2-one（1） and ~1H-[1,2,4]triazol-3-ylamine（2） with equal amount of K_2CO_3 as acid acceptor. The structure of compound 3 was characterized by ~1H NMR, 13 C NMR, HRMS and single-crystal X-ray diffraction. The compound crystallizes in the monoclinic system, space group P21/n with a = 5.7227（8）, b = 27.924（4）, c = 6.2282（7） ？, β = 101.892（11）°, V = 973.9（2） ？~3, Z = 4, T = 180.00（10） K, μ（MoKα） = 0.087 mm^（-1）, Dc = 1.243 g/cm^3, 3832 reflections measured（3.648≤θ≤26.022°）, 1916 unique reflections（Rint = 0.0359, Rsigma = 0.0572） used in all calculations. The final R = 0.0557（I 〉 2σ（I）） and w R = 0.1276（all data）. Bioassay showed that 3 displayed excellent activity as plant growth regulator with inducing lateral root formation and enhancing primary root elongation at 0.27 mmol/L（50 ppm） in soybeen（He Feng-50）. Good water solubility was found with 50 mg in 1 m L of water. Therefore, application of 3 in agriculture is more environmentally friendly due to cosolvent-free condition, and results in improved abiotic-stress tolerance by affecting the root growth. And furthermore, it can be used as a precursor to investigate the function of regulating plant root growth.

Synthesis and Molecular Structure of 4-Chloromethyl-3-anilino-2-(4-methylbenzoylimido)thiazole

The title compound 2, 4-chloromethyl-3-anilino-2-（4-methyl-benzoylimido）thiazole, was prepared by the reaction of 1-p-methylbenzoyl-3-phenylaminothiourea 1 with 1,3-dichloro- acetone. The crystal is of monoclinic, space group P21/c, with a = 8.1712（15）, b = 10.998（2）, c = 19.134（4）A, β= 94.610（5）°, C18H16ClN3OS, Mr = 357.85, Z = 4, V = 1714.0（6）A^3, De= 1.387 g/cm^3, μ（MoKa） = 0.354 mm^-1, F（000） = 744, the final R = 0.0518 and wR = 0.1167 for 3189 observed reflections （I〉 2σ（I）. Its formation mechanism was proposed.

3-氟偕二硝甲基-1,2,4-三唑的合成及性能

以3-氰基^(-1),2,4-三唑为原料,经肟化、重氮化-氯化、硝解、还原、氟化等反应合成了一种含氟偕二硝甲基官能团的新型含能化合物——3-氟偕二硝甲基^(-1),2,4-三唑(FDNMT),利用红外光谱、核磁(~1H NMR、^(13)C NMR)、元素分析和质谱等方法表征了化合物的结构;优化了肟化反应的合成条件:3-氰基^(-1),2,4-三唑和盐酸羟胺摩尔比为1∶1.15,p H值为8,反应时间为2 h,反应温度为60℃,收率为49.0%;获得了FDNMT的单晶并进行了晶体结构解析,该化合物晶体为正交晶系,空间群为Pbcn,晶体学参数为:a=7.4821(11),b=9.8106(15),c=38.683(6),V=2839.5(7)~3,Z=16,μ=0.178 mm^(-1),F(000)=1536;采用Gaussian 09程序中的CBS-4M方法计算了该化合物的生成热,基于密度和计算的生成热,利用Kamlet-Jacobs爆轰方程预估该化合物的爆轰性能:密度1.81 g·cm^(-3),生成热-8.7 k J·mol^(-1),爆速8365.0 m·s^(-1),爆压31.1 GPa,爆热为5614.4 k J·kg^(-1)。

1,5-二苯基-3-氯甲基硫代-1H-1,2,4-三唑的合成及晶体结构

无溶剂条件下1-苯甲酰基-3-苯氨基硫脲与二氯甲烷反应合成了目标产物1,5-二苯基-3-氯甲基硫代-1H-1,2,4-三唑,产物的结构通过红外光谱、核磁共振光谱、高分辨质谱和X射线衍射进行了表征。晶体结构显示其晶体属单斜晶系P21/c,a=9.5303(14),b=18.622(2),c=8.8307(13),β=116.767(3)°,Z=4,V=1399.3(3)3,Dc=1.433 g/cm3,μ(MoKα)=0.414 mm-1,F(000)=624,最终偏差因子R=0.0466,ωR=0.1027,其中,可观察衍射点为2827个(I>2σ(I))。

1H-3-(3-吡啶基)-5-(3′-吡啶基)-1,2,4-三唑的钴(Ⅱ)配合物的合成、晶体结构、热稳定性及配体的DFT计算（英文）

合成了一个多功能的配体1H-3-(3-吡啶)-5-(3′-吡啶)-1,2,4-三唑(3,3′-Hbpt,1)并得到了配体的晶体结构,运用DFT理论计算了配体的最优构型、优势构象和电荷分布。在此基础上,水热合成了一个配位化合物:[Co(3,3′-Hbpt)2(H2O)4]·(ad)·6H2O(2)(ad=己二酸),结构分析表明配合物2是零维单核化合物,它的三维超分子结构是由分子间氢键连接而成,其中包含着由游离的己二酸分子填充的矩形孔道。值得注意的是,配体在配合物中的几何结构和构象与理论计算的结果一致。另外,利用热重分析研究了配合物2的热稳定性。

4-氨基-1,2,4-三唑-3,5-二硝基苯甲酸盐的晶体结构、比热容及热力学性质

用4-氨基-1,2,4-三唑的甲醇溶液与3,5-二硝基苯甲酸的甲醇溶液合成了4-氨基-1,2,4-三唑-3,5-二硝基苯甲酸盐。室温下培养出单晶,通过X射线衍射测定晶体结构,晶体属于单斜系,空间群为C2/c,晶胞参数为:a=1.816 0(2)nm,b=0.481 8(5)nm,c=2.616 0(3)nm,α=γ=90°,β=101.764(16)°,V=2.241(4)nm3,Dc=1.756 g/cm3,Z=8,F(000)=1 216,R1=0.060 5,wR2=0.190 4。运用Micro-DSCⅢ微热仪测定化合物的比热容,298.15 K下标准摩尔比热容为247.23 J.mol-1.K-1,比热容与温度的关系式为:Cp=1.227 780-3.754 315×10-3T+8.176 156×10-6T2。用NETZSCH TASC 414/3A热分析仪研究了化合物的热分解行为,结果显示,该化合物的热分解过程包括一个吸热熔化过程和两个放热分解过程。

4-水杨醛亚氨基-3-烷基-1,2,4-三唑-5-硫酮合成和晶体结构

合成了5个4 - 水杨醛亚氨基- 3- 烷基- 1,2 ,4 -三唑- 5 - 硫酮化合物,并用IR和1 HNMR手段对这些化合物进行了表征.通过X Ray单晶衍射方法对化合物4 -水杨醛亚氨基- 3 -甲基-1,2 ,4 -三唑- 5 - 硫酮(IIa)结构进行了测定,确定该晶体属于单斜晶系,空间群为P2 1 n ,晶胞参数a =1.2 6 97(3) ,b =0 .74 0 7(15 ) ,c =1.2 75 0 (3)nm ,β=117.6 8(3)°,V =1.0 6 185 (4) (nm) 3,Z =4 ,Dc =1.4 6 5g cm3,μ=0 .2 88mm- 1 ,F(0 0 0 ) =4 88,R =0 .0 5 8,wR =0 .16 4 .其中独立衍射点数为2 6 6 0个,2 130个为可观察衍射点(I >2σ(I) )用于结构测定和修正.结果表明所有目标产物4 -水杨醛亚氨基-3- 烷基- 1,2 ,4 - 三唑- 5 - 硫酮(IIa～c ,IIId～e)中甲亚胺(CN)构型是E构型(反式) ,并且是硫酮式互变异构体而不是硫醇式,并且化合物的所有非氢原子共平面.

1，2，3-噻二唑联-1，2，4-三唑衍生物的合成及抑菌活性

以4-氨基-3-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑-5-硫酮为原料,与醛在冰乙酸中回流制得15个新型4-取代亚氨基-3-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑-5-硫酮化合物,其结构经IR、1H NMR及元素分析表征,其中,化合物5c的结构经单晶测试确证,该晶体属单斜晶系,P2(1)/c空间群,晶胞参数a=1.403 7(3)nm,b=1.570 5(3)nm,c=0.6864(14)nm,β=102.06(3)°,V=1.4798(5)nm3,Z=4,F(000)=656。初步的抑菌活性测试结果表明;所有化合物对黄瓜灰霉病菌Botrytis cinerea都有较好的抑制作用,化合物5l的抑制率达87%,5c、5d和5f的抑制率在78%左右;5a对小麦赤霉病菌Gibberella zeae的抑制率为78.7%;5m对西瓜炭疽病菌Colletotrichum lagenarium的抑制率为65.6%。

基于2-(4-苯基-1,2,3-三唑)亚甲基吡啶(PTMP)的过渡金属配合物的合成与晶体结构

本文报道了一类基于 2-(4-苯基-1,2,3-三唑)亚甲基吡啶(PTMP)配体的过渡金属镍、钴和锌配合物的合成,并通过单晶衍射实验确定了它们的晶体结构。研究结果表明,在这类金属配合物中,PTMP 均通过吡啶氮原子和 1,2,3-三唑中的 2 位氮原子与金属配位,并形成了六元螯合环。在 Co髤及 Ni髤的配合物中,有 2 个 PTMP 参与配位,配位数为 6,配合物的空间构型是畸变的八面体;而在 Zn髤中则只有 1 个 PTMP 参与配位,配位数为 4,配合物的空间构型是变形的四面体。晶体结构数据分析及理论计算结果表明,尽管 PTMP 分子中 1,2,3-三唑环上的 2 位氮原子相对于 3 位氮原子而言,电子云密度较低,但在这类配合物中由于"螯合效应"2 位氮原子仍然表现出了较强的配位能力。

1-三硝甲基-3-硝基-1,2,4-三唑的晶体结构及性能预估

为了获得1-三硝甲基-3-硝基-1,2,4-三唑(TNMNT)的晶体结构并对其性能进行预估,以3-硝基-1,2,4-三唑为原料,通过取代、硝化反应合成出了TNMNT,收率为62%,以无水乙醇为溶剂,用溶剂蒸发法培养得到纯的TNMNT单晶,并采用核磁共振谱、红外光谱与X-射线单晶衍射仪进行了结构表征。用DSC-TG法分析了热稳定性。用Gaussian 09 and EXPLO5(V6.02)程序分别计算了生成焓和爆轰参数。结果表明:TNMNT晶体属于单斜晶系,空间群P21/c,晶体参数为a=6.643(3),b=20.494(7),c=6.698(3),β=94.225(9)°,V=909.4(6)3,Z=4,Dc=1.922 g·cm^(-3),μ=0.190 mm^(-1),F(000)=528.0。5℃·min-1升温速率下,TNMNT的热分解峰温为158.3℃。它的标准生成焓为210.9 kJ·mol^(-1),爆速为9023 m·s^(-1),爆压为35.5 GPa。大量分子间和分子内氢键作用的存在使TNMNT分子稳定存在,硝仿基团的引入使TNMNT分子的能量提高。

1,2,3-三唑羧酸铜(Ⅱ)配合物的合成、晶体结构与性质

通过水热的方法制备了两个新的1,2,3-三唑羧酸铜配合物:[Cu(L^1)_2·2H_2O](1)和[Cu(L^2)_2]_n(2)(HL^1=4-苯基-1,2,3-三唑-1-乙酸,HL^2=4-苯基-1,2,3-三唑-2-乙酸),并利用红外光谱、质谱(MS)、核磁共振氢谱(~1H NMR)、元素分析、X-射线单晶衍射、X-射线粉末衍射和热重分析进行了表征。晶体结构表明:配合物1中,每一个单核分子通过分子间氢键作用形成二维层状结构。配合物2中,铜原子通过与羧基上的氧原子采用顺-反双齿桥联,形成了二维的网状结构,进一步通过每层网状结构间的π-π堆积作用形成三维超分子结构。磁性测试结果表明配合物2在低温下表现为铁磁性相互作用。

C—N键联唑类高氮含能化合物1-(1H-1,2,4-三唑-3-基)-1H-四唑金属盐的合成与性能

通过C—N键联唑类高氮含能化合物1(?1H?1,2,4?三唑?3?基)?1H?四唑分别与相应的氢氧化物或碳酸盐反应,合成了7种未见报道的1(?1H?1,2,4?三唑?3?基)?1H?四唑金属盐。利用元素分析、红外光谱、质谱等对其结构进行了表征,首次培养得到了其中5种金属盐的单晶,测试了其晶体结构。运用差示扫描量热分析(DSC)研究了该系列金属盐的热稳定性,大部分金属盐均具有较好的热稳定性,其中锂盐脱水后的热分解温度最高(258℃)。利用等键反应计算了部分金属盐的生成焓,其中两种金属盐的生成焓高于1000 k J·mol^(-1)。运用EXPLO5软件估算其爆炸性能,并测试了撞击感度和摩擦感度,结果表明该系列金属盐属于钝感含能材料。

新型钴配合物[Co(chedc)(4,4＇-bpt)2(H2O)3]NO3·H2O的合成及其晶体结构

以顺-4-环己烯-1,2-二羧酸(chedc)、3,5-二(4-吡啶基)-1,2,4-三氮唑(4,4'-bpt)、六水合硝酸钴为原料,通过室温条件下自然挥发得到一个单核Co(II)的配合物[Co(chedc)(4,4'-bpt)_2(H_2O)_3]NO_3·H_2O(1),其结构经IR、元素分析、X-射线单晶衍射进行表征.晶体属单斜晶系,空间群P21/c,晶胞参数a=1.198(2)nm,b=1.361(3)nm,c=2.202(4)nm,β=92.65(3)°,V=3.584(12)nm3,Z=4,Dc=1.499 g·cm-3,F(000)=1676,R1=0.0627,ωR2=0.1190.

基于2,3-吡嗪二酸和双三唑丁烷的锌配合物的合成及其晶体结构与性质

通过双三唑丁烷、2,3-吡嗪二酸与硝酸锌的自组装反应,合成了一种新型的具有二维波浪状结构的锌配合物，分子式为{[Zn（pzdc）（btb）0.5（H2O）2]·H2O}n（H2pzdc=2,3-吡嗪二酸，btb=双三唑丁烷），X-射线衍射分析表明该配合物具有3-连接的（6,3）拓扑结构.配合物的Zn^Ⅱ中心通过吡嗪二酸阴离子组装成一维之字链,而之字链之间又通过柔性的双三唑丁烷配体桥连成奇特的二维波浪状结构.通过分子内和分子间O-H…N和O-H…O的氢键作用,配合物最终形成三维的超分子结构.同时对配合物的焚光性质和热稳定性质进行了讨论.